While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial ...

Lundbeck’s strong Q1, undervaluation, and pipeline potential offset policy and clinical risks, with upside tied to key ...

Right to Try laws are being adopted and expanded throughout the country. In one state, they’ll allow healthy people to access ...

Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

Moderna (NasdaqGS:MRNA) initiated the dosing for its innovative mRNA-4106 cancer therapy in a Phase 1 trial, signaling ongoing advancements in their oncology pipeline. However, the company's stock ...

Tell us about the product or service that Inductive Bio offers.

Despite securing a much-needed $5 million lifeline from an equity offering this week, HCW Biologics is continuing to warn ...

Though it may be a while before similar personalized treatments are available for others, doctors hope the technology can ...

Novo Nordisk announced it will work with the biotech Septerna to develop oral GLP-1 obesity drugs in a deal worth up to $2.2 ...

Subungual melanoma which appears under fingernails and toenails, is a rare but serious form of skin cancer that typically isn ...

Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ('Conduit” or the 'Company”), a dynamic, multi-asset clinical stage, life science company delivering an efficient model for compound development, announces ...